Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 13/20 | 0.57 |
| ▸ | MMP8 | P22894 | 4/20 | 0.57 |
| ▸ | MMP13 | P45452 | 1/20 | 0.57 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 12/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MMP12 | P39900 | 3/20 | 0.45 |
| ▸ | MMP14 | P50281 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NSD2 | O96028 | 2/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5706285 | 1.00 | MMP9 (0.57) | MMP9MMP8MMP13ADAMTS4MMP2 | |
| SCHEMBL4137790 | 0.91 | MMP9 (0.60) | MMP9MMP8MMP13ADAMTS4MMP2 | |
| SCHEMBL3465132 | 0.91 | MMP9 (0.60) | MMP9MMP8MMP13ADAMTS4MMP2 | |
| SCHEMBL5149287 | 0.88 | MMP9 (0.44) | MMP9MMP8MMP13ADAMTS4MMP2 | |
| SCHEMBL8842858 | 0.87 | NSD2 (0.45) | MMP9MMP8MMP13ADAMTS4L3MBTL1 | |
| SCHEMBL6266412 | 0.86 | PKLR (0.50) | MMP9MMP2NSD2 | |
| SCHEMBL1168298 | 0.85 | MMP2 (0.46) | MMP9MMP8MMP2MMP12MMP14 | |
| SCHEMBL319322 | 0.85 | MMP9 (0.61) | MMP9MMP8MMP13ADAMTS4MMP2 | |
| SCHEMBL180020 | 0.85 | NSD2 (0.45) | MMP9ADAMTS4MMP2NSD2 | |
| SCHEMBL9670221 | 0.85 | NSD2 (0.45) | NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005768-A | Orthogonal modified human serum albumin, preparation method and application thereof | 华东理工大学 | 2024-05-10 | — | — | CN | claimed |
| CN-118005768-A | Orthogonal modified human serum albumin, preparation method and application thereof | 华东理工大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-118005768-A | Orthogonal modified human serum albumin, preparation method and application thereof | 华东理工大学 | 2024-05-10 | — | — | CN | disclosed |
| US-7572357-B2 | The concentration of analyte is achieved by balancing the electrophoretic velocity of an analyte against the bulk flow of solution in the presence of a temperature gradient | The United States of America as represented by the Secretary of Commerce, the National Institute of Standards and Technology (US) | 2009-08-11 | — | — | US | disclosed |
| US-20050258040-A1 | Chiral temperature gradient focusing | GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF COMMERCE, THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY | 2005-11-24 | — | — | US | disclosed |
| US-6329546-B1 | FOR INVESTIGATING THE MECHANISM OF ACTION OF A PHYSIOLOGICALLY ACTIVE AMINO ACID COMPOUND SUCH AS GLUTAMIC ACID IN AN ORGANISM | LABORATORY OF MOLECULAR BIOPHOTONICS (JP) | 2001-12-11 | — | — | US | disclosed |
| US-5594545-A | Microflow cell | NIHON BUNKO KABUSHIKI KAISHA (JP) | 1997-01-14 | — | — | US | disclosed |
| EP-0476248-B1 | Microflow cell | JAPAN SPECTROSCOPIC CO (JP) | 1996-04-03 | — | — | EP | disclosed |
| EP-0476248-A1 | Microflow cell | NIHON BUNKO KOGYO KABUSHIKI KAISHA (JP) | 1992-03-25 | — | — | EP | disclosed |
| US-4540548-A | Method of detecting fluorescent materials and apparatus for their detection | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1985-09-10 | — | — | US | disclosed |
| US-4419452-A | Method of detecting fluorescent materials and apparatus for their detection | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1983-12-06 | — | — | US | disclosed |